These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25656965)
1. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study. Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965 [TBL] [Abstract][Full Text] [Related]
2. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome. Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874 [TBL] [Abstract][Full Text] [Related]
3. DNMT3B polymorphisms and risk of primary lung cancer. Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220 [TBL] [Abstract][Full Text] [Related]
4. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study. Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598 [TBL] [Abstract][Full Text] [Related]
5. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer]. Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141 [TBL] [Abstract][Full Text] [Related]
6. Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma. Lao Y; Wu H; Zhao C; Wu Q; Qiao F; Fan H Biomed Rep; 2013 Sep; 1(5):771-775. PubMed ID: 24649027 [TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161 [TBL] [Abstract][Full Text] [Related]
8. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385 [TBL] [Abstract][Full Text] [Related]
9. Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer. Bao Q; He B; Pan Y; Tang Z; Zhang Y; Qu L; Xu Y; Zhu C; Tian F; Wang S Int J Colorectal Dis; 2011 Sep; 26(9):1107-12. PubMed ID: 21519807 [TBL] [Abstract][Full Text] [Related]
10. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes. Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449 [TBL] [Abstract][Full Text] [Related]
12. The DNMT3B -579G>T Polymorphism Is Significantly Associated With the Risk of Gastric Cancer but not Lung Cancer in Chinese Population. Chen B; Wang J; Gu X; Zhang J; Zhang J; Feng X Technol Cancer Res Treat; 2017 Dec; 16(6):1259-1265. PubMed ID: 29332452 [TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase 3B (DNMT3B -579G>T) promotor polymorphism and the susceptibility to pediatric immune thrombocytopenic purpura in Egypt. Khorshied MM; El-Ghamrawy MK Gene; 2012 Dec; 511(1):34-7. PubMed ID: 23000068 [TBL] [Abstract][Full Text] [Related]
14. DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians. Shaheen IA; Abukhalil RE; Ali DK; Afifi RA Blood Coagul Fibrinolysis; 2012 Oct; 23(7):636-9. PubMed ID: 22885766 [TBL] [Abstract][Full Text] [Related]
15. MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. Rai AK; Singh S; Mehta S; Kumar A; Pandey LK; Raman R J Hum Genet; 2006; 51(4):278-283. PubMed ID: 16489479 [TBL] [Abstract][Full Text] [Related]
16. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Aung PP; Matsumura S; Kuraoka K; Kunimitsu K; Yoshida K; Matsusaki K; Nakayama H; Yasui W Oncol Rep; 2005 Nov; 14(5):1151-4. PubMed ID: 16211278 [TBL] [Abstract][Full Text] [Related]
17. Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer. De Castro TB; Rodrigues-Fleming GH; Oliveira-Cucolo JG; Silva JNGD; Silva FP; Raposo LS; Maniglia JV; Pavarino EC; Batista Arantes LMR; Galbiatti-Dias ALS; Maria Goloni Bertollo E Asian Pac J Cancer Prev; 2020 Dec; 21(12):3751-3759. PubMed ID: 33369477 [TBL] [Abstract][Full Text] [Related]
18. Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer. Wang C; Jia Z; Cao D; You L; Jin M; Wu X; Wen S; Cao X; Jiang J PLoS One; 2015; 10(8):e0134059. PubMed ID: 26262893 [TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Jung AY; Poole EM; Bigler J; Whitton J; Potter JD; Ulrich CM Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):330-8. PubMed ID: 18268116 [TBL] [Abstract][Full Text] [Related]
20. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study. Fan H; Zhang F; Hu J; Liu D; Zhao Z J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]